TMEM39B Activators
TMEM39B Activators constitute a specific category of chemical compounds that have gained recognition within the field of molecular biology and cellular research. These activators are tailored to modulate the activity of the TMEM39B gene, with TMEM39B denoting Transmembrane Protein 39B. This gene encodes a protein found in humans, which belongs to the larger family of transmembrane proteins. While the precise biological functions of TMEM39B are still under investigation, this gene's product is believed to be involved in various cellular processes, potentially contributing to membrane dynamics, signal transduction, or cell-to-cell communication. TMEM39B Activators represent a group of molecules designed to enhance or stimulate the expression and function of the TMEM39B gene, leading to increased activity of the associated protein.
The underlying mechanism by which TMEM39B Activators exert their effects typically involves interactions with specific regulatory elements within the TMEM39B gene, such as its promoter or enhancer sequences. These interactions facilitate the upregulation of gene transcription, culminating in heightened synthesis of the TMEM39B protein. Researchers are actively exploring the precise role of TMEM39B in cellular processes and its downstream effects, aiming to unravel its significance in the context of cell biology and molecular pathways. As scientists continue to investigate the functions and potential implications of TMEM39B activation, the development and optimization of TMEM39B Activators hold promise for advancing our understanding of transmembrane proteins and their involvement in diverse cellular activities.
SEE ALSO...
Items 1 to 10 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in various signaling pathways, potentially upregulating TMEM39B as part of membrane-associated signaling events. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ADP-ribosylation factor (ARF), a small GTPase involved in vesicle trafficking between the Golgi and the endoplasmic reticulum. By inhibiting ARF, Brefeldin A disrupts the trafficking and localization of TMEM39B, leading to its functional inhibition. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients. It affects the Golgi function by altering its pH, which can subsequently inhibit the correct localization and function of TMEM39B within the Golgi apparatus. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels and potentially enhancing the expression of TMEM39B through cAMP response element-binding proteins. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation by blocking the first step in the synthesis of the lipid-linked oligosaccharide precursor. This can inhibit the glycosylation of TMEM39B, which is necessary for its proper folding and function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin. Since calcineurin mediates dephosphorylation events that affect the trafficking and function of transmembrane proteins, its inhibition could disrupt the function of TMEM39B. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces ER stress by disrupting calcium homeostasis, potentially enhancing TMEM39B expression as part of cellular adaptation to maintain ER function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, a GTPase required for vesicle scission during endocytosis. Inhibition of endocytosis could impair the recycling and distribution of TMEM39B to its appropriate cellular locations, thereby inhibiting its function. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
As a major component of cell membranes, altering cholesterol levels could modulate the expression of membrane proteins like TMEM39B to maintain membrane integrity and function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If TMEM39B function depends on phosphorylation by a tyrosine kinase, genistein could inhibit its activity by preventing this phosphorylation. | ||||||